PLC η2 inhibitors refer to a class of chemical compounds that have been investigated for their potential to modulate the activity of PLC η2 (Phospholipase C eta-2), an enzyme belonging to the phospholipase C (PLC) family. PLC η2 plays a critical role in intracellular signal transduction by catalyzing the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). These secondary messengers then trigger a cascade of downstream cellular responses, including calcium release and activation of protein kinase C (PKC). The exploration of PLC η2 inhibitors has arisen from the scientific interest in understanding the functional significance of PLC enzymes in cellular signaling. By targeting PLC η2, these inhibitors aim to interfere with its catalytic activity, disrupting the generation of IP3 and DAG and consequently modulating downstream cellular responses. This interference may lead to alterations in cellular communication and intracellular signaling pathways, providing valuable insights into the role of PLC η2 in cellular physiology and homeostasis.
Chemically, PLC η2 inhibitors encompass a diverse array of compounds, each designed to interact with specific structural motifs or active sites within the PLC η2 enzyme. Researchers explore various chemical scaffolds and modifications to achieve selectivity and potency in inhibiting PLC η2 while minimizing potential off-target effects. The study of PLC η2 inhibitors is an active area of research within the field of cellular signal transduction and intracellular communication. Through rigorous experimentation and characterization of these inhibitors, scientists aim to elucidate their mode of action and their effects on PLC η2 activity and substrate specificity. The identification of PLC η2 inhibitors holds the promise of providing valuable tools for investigating the functional roles of PLC enzymes in cellular signaling. It is vital to emphasize that the current focus of studying PLC η2 inhibitors remains rooted in fundamental scientific inquiry and advancing our understanding of cellular signal transduction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
R 59-022 | 93076-89-2 | sc-203227 | 5 mg | $122.00 | 1 | |
A compound that has been reported to inhibit PLC activity, including PLC η2. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $500.00 | ||
A naturally occurring compound found in Chromobacterium violaceum, which has been studied for its inhibitory effects on some PLC isoforms. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $26.00 $34.00 | 20 | |
An aminoglycoside antibiotic that can inhibit PLC activity, including PLC η2. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
A non-selective beta-blocker that may have inhibitory effects on certain PLC isoforms. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $185.00 $564.00 | 7 | |
A compound that has been reported to inhibit PLC activity, but its specificity for PLC η2 is not well-defined. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
A natural compound found in grapes and red wine, which has been reported to inhibit PLC activity, including PLC η2. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
A compound that can activate adenylyl cyclases, which indirectly affects PLC η2 activity through crosstalk in signal transduction pathways. | ||||||